It can be important to include clinical variables not found in claims data when carrying out propensity score matching

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.591, 2009-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia

By Polsky Daniel  

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 755-765

Adis International

Access to resources Recommend Favorite

Discussion of: Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies

By Zhou Zheng   Lam Peter  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 1, 2007-01 ,pp. : 25-27

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies

By Yue Lilly  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 1, 2007-01 ,pp. : 1-13

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of: Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies

By Wright David   Day Simon  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 1, 2007-01 ,pp. : 15-17

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discussion of: Statistical and Regulatory Issues with the Application of Propensity Score Analysis to Nonrandomized Medical Device Clinical Studies

By D'Agostino Ralph  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 1, 2007-01 ,pp. : 29-33

Taylor & Francis Ltd

Access to resources Recommend Favorite